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The novel nucleoside 5-iodo-4-thio-2¤-deoxy-
uridine (4) was synthesized and fully charac-
terized by IR, NMR, and MS. Its structure was
determined by single-crystal X-ray diﬀraction.
Compound 4 absorbs strongly at 346 nm and is
minimally toxic to human tumour cells, but its
cytotoxicity is substantially enhanced by low
dose UVA radiation. The combined use of 4 and
UVA oﬀers a promising route to selectively and
eﬀectively kill proliferating cells.
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The novel nucleoside 5-iodo-4-thio-2¤-deoxyuridine (4) was
synthesized and fully characterized by IR, NMR, and MS. Its
structure was determined by single-crystal X-ray diﬀraction.
Compound 4 absorbs strongly at 346 nm and is minimally toxic
to human tumour cells, but its cytotoxicity is substantially
enhanced by low dose UVA radiation. The combined use of 4
and UVA oﬀers a promising route to selectively and eﬀectively
kill proliferating cells.
Nucleic acids (DNA and RNA) direct the ﬂow of genetic
information. In addition to the four canonical bases, structurally
similar base analogues can be incorporated into DNA. These
alter its properties and facilitate basic studies of DNA-related
processes such as its interaction with proteins, replication, and
transcription. Site-speciﬁcally modiﬁed bases and nucleosides
are particularly useful in this regard, and thiobases, in which
an oxygen atom in the base is replaced by sulfur,1­3 have
proved invaluable in studies of DNA duplex stability, protein
recognition, and replication.4­6 We have been exploring the
photochemical properties of thiobases and their derivatives,
particularly 6-thioguanine (6-TG) and 4-thiothymidine (4-
thioTdR). Unlike canonical DNA bases, both are strong UVA
chromophores and are extremely sensitive to wavelengths of
315­400 nm (UVA range). Upon exposure to UVA radiation,
DNA-embedded 6-thioguanine is oxidized to guanine-6-
sulﬁnate and guanine-6-sulfonate in an oxygen-dependent
reaction.7­9 UVA irradiation of cells containing DNA 6-TG also
induces DNA strand breakage and interstrand crosslinking.10
These DNA lesions block replication and transcription and
cause cell death.11 DNA 4-thioTdR also displays synergistic
lethality with UVA radiation. It undergoes UVA-mediated
conversion to potentially cytotoxic lesions including inter- and
intrastrand DNA crosslinks.12 In the absence of UVA, cells can
accumulate signiﬁcant levels of 4-thioTdR without detrimental
eﬀects on proliferation.13,14 The combined use of 4-thioTdR
and UVA oﬀers a novel approach to selectively kill rapidly
proliferating cells, such as cancer cells, while causing minimal
damage to normal tissues.15 The advantage this synergistic
photoactivation of DNA thiobases has over conventional
therapies is that it can target proliferating cells more selective-
ly. We have therefore explored the properties of additional 4-
thioTdR analogues and have previously reported the synthesis
and chemical properties of 5-bromo-4-thio-2¤-deoxyuridine.16
Here we report a synthetic route for 5-iodo-4-thio-2¤-deoxy-
uridine. We also describe its crystal structure and initial studies
of its cytotoxicity.
The synthetic route is shown in Scheme 1 in which the
starting material 1 was ﬁrst acetylated at its 3¤- and 5¤-positions
to give the acetylated nucleoside 2, followed by a thiolation at
the 4-postion to give the protected 4-thio-nucleoside 3. This was
then deprotected to aﬀord the target product 4. Previously we
used triazole/POCl3 and thioacetic acid to produce 3.17a The
current synthesis is straightforward and proceeds with good
yields (see ESI for details). The intermediates 2 and 3 and
the product 4 were fully characterized by MS, UV, IR spectra,
1HNMR and 13CNMR measurements (see ESI for details).
Some key spectral data of 1 and 4 are summarized in Table 1 for
comparison.
The spectral characterization provides a good conﬁrmation
for the structure of 4. High-resolution MS analysis of 4 gave
an ion at 392.9382 for the molecular fragment (M + Na+), the
m/z being within 1 ppm of the calculated m/z (392.9378) for
C9H11IN2NaO4S. 4 absorbs strongly at 346 nm, substantially
shifted from the 290 nm maximum of 1 (Figure S1, see ESI).
This red shift reﬂects the presence of the sulfur atom.16 The
observed band at 1088 cm¹1 in the infrared spectrum is within
the characteristic range (1070­1150 cm¹1) assigned to the C=S
stretching mode of the thioamide group in 4-thiouridine,18
indicating the presence of the C4=S group in 4. NMR data
oﬀer further support. D2O exchange experiments readily identify
the signal in ¤H 12.99 ppm as proton N3­H. The presence of the
thioamide in 4 is also evident from the substantial NMR
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Scheme 1. Synthesis of 5-iodo-4-thio-2¤-deoxyuridine (4).
(i) Ac2O/pyridine (91% for 2); (ii) P4S10/1,4-dioxane (74%
for 3); (iii) NH3(g)/MeOH (68% for 4).
Table 1. Key spectral data of compounds 1 and 4
Cpd
UV
(­max/nm)
IR
/cm¹1
1HNMR
(N3­H)/ppm
13CNMR
(C4)/ppm
1 290 1677 (C4=O) 11.66 160.48
4 346 1088 (C4=S) 12.99 189.31
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chemical shifts17 of N3­H (12.99 from 11.66) and of C4 (189.31
from 160.48) (Table 1).
The molecular structure and absolute conﬁguration of 4
(Figure 1) was conﬁrmed by single-crystal X-ray diﬀraction
analysis.
The structure belongs to the triclinic system and space group
P1 (Table S1, see ESI). It is worth noting that the unit cell of the
crystal structure of 5-iodo-4-thio-2¤-deoxyuridine contains three
independent molecules (Figure S2, see ESI). It is not unusual to
have two independent molecules of a nucleoside in a single unit
cell, for example deoxyuridine and 5-bromo-2¤-deoxyuridine,19
but it is rare for the same unit cell to contain three or more
nucleosides.20
Figure 2 shows the comparison of the lengths and angles of
individual bonds in the bases 4 (5-iodo-4-thio-2¤-deoxyuridine)
and 1 (5-iodo-2¤-deoxyuridine).21 Overall, these two molecular
structures are very similar, except the bond involving the sulfur
atom at the 4-position. The thiocarbonyl (C4=S) bond in 4 is
substantially longer than the carbonyl (C4=O) bond in 1. The
average length (from three individual molecules of 4) of C4=S
bond is 1.662¡ and is similar to that of the documented C=S
bond of 4-thiouracil derivatives (1.672¡) and the mean C=S
distance (1.654­1.665¡) reported by Allen et al.22 This length
is much shorter than a standard C­S single bond of 1.80¡,
demonstrating that the thiocarbonyl group is in fact a double
bond. The angle ¾SC4C5 (126°) is slightly wider than the angle
¾OC4C5 (122°), and the C4=S bond tilts away from the iodo
group at the 5-position.
In the crystal lattice each of three independent molecules are
linked together by an intermolecular hydrogen-bond network
(Figure S3, see ESI). Each independent molecule serves as a
donor and acceptor of moderate O­H£O (D£A µ 2.765¡) and
N­H£O (D£A µ 2.285¡) type hydrogen bonds. Additionally,
each sulfur atom is involved in a weak O­H£S (D£A µ
3.394¡) hydrogen bond (Table S2). The C=S bond is known
to have a broader distance range and to be less polar than a
Cδ+=Oδ¹ bond, thus it is also a weaker hydrogen bond acceptor.
For C=S acceptors, the mean hydrogen bond distances are more
than 0.5¡ longer than for C=O acceptors. This is also larger
than the diﬀerence of the S and O van der Waals radii and
the lone-pair directionality at C=S acceptors is very pro-
nounced.22,23 Interestingly, systematic studies by Allen et al.22
showed that only the longer C=S bonds appear to be involved in
hydrogen bonding (the percentage of hydrogen bonds formed by
C=S increases systematically from 5% to 75% as the C=S bond
length increases from 1.63 to 1.75¡). Detailed bond lengths and
angles for the three individual molecules present in the crystal
structure of 4 are available from the CCDC, depository number:
959345.
5-Iodo-2¤-deoxyuridine (1) was one of the ﬁrst selective
antiviral nucleosides.24 It is still used in the treatment of various
diseases including herpetic keratitis25 and for radiosensitization
of high-grade gliomas.26 Previously we showed 4-thioTdR has
very similar base-pairing properties to thymidine.14 As 4 and 1
diﬀer only slightly in structure, it is highly likely that their
behavior would be similar in terms of incorporation into viral
DNA and base-pairing. However, the strong UVA absorption of
4 would enhance its potential as an UVA-mediated antiviral
agent or DNA probe. We therefore examined the eﬀects of
photochemical activation of 4 on human cells growing in culture.
Compound 4 was toxic to cultured human cells only at high
¯M concentrations. Figure 3 shows the eﬀects of compound 4
on the viability of the human oral cell carcinoma CA-1 cells.
Continuous 24 h exposure induced a dose-dependent increase in
cytotoxicity with an approximate LD50 of 320¯M. Clearly 4 was
minimally toxic to the cultured human cells.
Figure 1. Molecular structure and absolute conﬁguration of 4.
Only one independent molecule present in the crystal structure
is shown. Full structural data are deposited at the Cambridge
Crystallographic Data Centre, depository number: 959345.
Figure 2. Selected bond lengths (¡) and angles (°) of the bases
in 4 and 1. For compound 4 the average values of cell bond
distances and angles of three independent molecules present in
the asymmetric part of the unit are shown.
Figure 3. Dose-dependent cytotoxicity of 4 in human oral cell
carcinoma CA-1 cells. The solid line is the experimental data
and the dotted line is a ﬁtted curve.
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The toxicity of 4 towards human HEK293 embryonic
kidney cells was similar and treatment with 100 or 200¯M for
48 h reduced survival by 10­20% (Figure 4). Direct analysis of
DNA from treated cells conﬁrmed a dose-dependent accumu-
lation of 4 in DNA. The presence of DNA-embedded 4 was
associated with a signiﬁcant sensitization to nontoxic dose of
UVA (340 nm) (Figure 4).
UVA doses up to 20 kJm¹2 caused only ¯10% toxicity in
the absence of drug pretreatment, but cell survival was
signiﬁcantly reduced after combined compound 4/UVA treat-
ment in both a UVA-dependent and compound 4-dependent
fashion. At the highest drug concentration (200¯M) and
20 kJm¹2, UVA reduced cell viability by >99.5%. These
preliminary results suggest that 5-iodo-4-thio-2¤-deoxyuridine
in combination with UVA is more cytotoxic than 5-bromo-4-
thio-2¤-deoxyuridine.16 This increased cytotoxicity of 4 might
reﬂect a lower bond enthalpy for the C­I bond27 (e.g. DH298 =
241 kJmol¹1 for CH3­I) compared to that for C­Br bond (e.g.
DH298 = 302 kJmol¹1 for CH3­Br), suggesting 5-iodo-4-thio-
2¤-deoxyuridine would be more susceptible to UVA-induced
activation than 5-bromo-4-thiodeoxyuridine.16 Studies are
ongoing to deﬁne the nature of the lethal DNA lesions and the
mechanism of cytotoxicity of the 5-iodo-4-thio-2¤-deoxyuridine/
UVA combination.
In conclusion, a UVA-sensitive nucleoside, 5-iodo-4-thio-
2¤-deoxyuridine, has been synthesized in a good yield and fully
characterized by spectroscopy. A single-crystal structure was
also obtained by X-ray analysis. The thio-nucleoside was
incorporated eﬀectively into DNA of cultured human cells.
This caused a modest antiproliferative eﬀect that was greatly
enhanced by low doses of UVA radiation. The combined use of
5-iodo-4-thio-2¤-deoxyuridine and UVA oﬀers a promising route
to selectively and eﬀectively kill proliferating cells.
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